Breaking News Instant updates and real-time market news.

LHCG

LHC Group

$96.20

3.08 (3.31%)

16:38
11/15/18
11/15
16:38
11/15/18
16:38

LHC Group initiated with a Buy at UBS

UBS analyst Whit Mayo initiated LHC Group with a Buy rating and a price target of $109.

  • 11

    Dec

LHCG LHC Group
$96.20

3.08 (3.31%)

11/01/18
WBLR
11/01/18
NO CHANGE
WBLR
Outperform
LHC Group shares could see pressure ahead of call, says William Blair
While LHC Group's organic growth trends were strong in Q3, "this was not a clean quarter," William Blair analyst Matt Larew tells investors in a post-earnings research note.The sales miss and "disconnect from expectations," which were looking for a beat-and-raise quarter, could pressure the stock ahead of today's earnings conference call, says Larew. The analyst adds that LHC's earnings release came less than an hour after the Centers for Medicare & Medicaid Services released the final 2019 home health rule. Though this looks to be largely in line with expectations, Larew contends. He keeps an Outperform rating on shares of LHC Group.
10/26/18
CHLM
10/26/18
DOWNGRADE
Target $92
CHLM
Hold
LHC Group downgraded to Hold from Buy at Craig-Hallum
Craig-Hallum analyst Kevin Ellich downgraded LHC Group to Hold from Buy and lowered his price target to $92 from $99, telling investors in a research note that he believes uncertainty related to the potential rate cut in 2020 from Medicare's proposed Patient-Driven Groupings Model will remain an overhang on shares. While the final 2019 Medicare Home Health rule should be released in the coming days, the analyst does not expect any major changes from the proposed rule and uncertainty related to PDGM will likely keep shares of LHC Group range-bound in the near-term, especially with the stock trading at a hefty premium to its historical averages. Further, Ellich says that while he expects "solid" Q3 results and believe the integration of Almost Family is likely going well, he thinks guidance will be maintained and that Q4 consensus EPS appears "off due to the sharp increase in share count attributable to the Almost Family deal."
10/26/18
CHLM
10/26/18
DOWNGRADE
CHLM
Hold
LHC Group downgraded to Hold from Buy at Craig-Hallum
10/11/18
SPHN
10/11/18
NO CHANGE
SPHN
Stephens says home health final rule looking like draft would weigh on providers
Stephens analyst Dana Hambly said he expects the final rule for home health reimbursement to be released by CMS in the first week of November. He is concerned that if the final rule looks similar to the draft rule, particularly regarding behavioral assumptions, it would weigh on home health stocks. For-profit, urban providers with higher percentages of therapy visits are estimated to take the largest cuts under a Patient Driven Groupings Model for reimbursement, said Hambly, who sees the impact being largest for Brookdale Senior Living (BKD) and Humana's (HUM) Kindred at Home. Others that may be impacted include Amedisys (AMED), Encompass Health (EHC), Ensign Group (ENSG) and LHC Group (LHCG).

TODAY'S FREE FLY STORIES

Get Full Fly Access

Breaking market intelligence sent straight to you
Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.
Up-to-date information on important industry events
Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.
News focused on the companies in your portfolio
Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.